Causes of Persistent Hyperglycemia
Persistent hyperglycemia results from inadequate insulin action (either insufficient secretion or resistance) combined with increased hepatic glucose output, and is most commonly perpetuated by type 2 diabetes, medication non-adherence, intercurrent illness/stress, or inappropriate insulin regimens.
Primary Pathophysiologic Mechanisms
The fundamental causes operate through two main pathways 1:
- Insulin deficiency/dysfunction: Progressive β-cell failure in type 2 diabetes (which accounts for 90-95% of all diabetes cases) leads to relative insulin deficiency combined with peripheral insulin resistance
- Increased hepatic glucose production: Dysregulation of normal circadian hormonal patterns results in excessive hepatic glucose output, particularly manifesting as fasting hyperglycemia 2
Glucose toxicity creates a vicious cycle - chronic hyperglycemia itself damages pancreatic β-cells, further impairing insulin synthesis and secretion, which perpetuates the hyperglycemia 3. This is why early aggressive control is critical.
Common Clinical Causes
In Hospitalized Patients
The most preventable causes in acute care settings include 4:
- Intercurrent infections (most common precipitant) 5
- Inadequate prescribing practices: Exclusive reliance on sliding-scale insulin without basal coverage
- Provider unwillingness to manage diabetes actively
- Medication effects: Glucocorticoids, second-generation antipsychotics, SGLT2 inhibitors 1
- Stress states: Myocardial infarction, sepsis, COVID-19 infection 1
- Failure to adjust therapy when oral intake decreases 4
In Outpatient/Chronic Settings
- Medication non-adherence 5
- Undiagnosed or undertreated diabetes 1
- Progressive disease: Type 2 diabetes is inherently progressive with declining β-cell function over time
- Substance abuse (cocaine, other illicit drugs) 1
- Dawn phenomenon: Fasting hyperglycemia from increased nocturnal hepatic glucose output without antecedent hypoglycemia 2
Special Populations and Genetic Causes
Glucokinase-MODY (GCK-MODY) should be considered in patients with 6:
- Mild persistent fasting hyperglycemia (5.4-8.3 mmol/L) present from birth
- HbA1c 5.8-7.6% (40-60 mmol/mol)
- Family history across multiple generations
- Absence of microvascular complications despite years of hyperglycemia
- Critical point: These patients do NOT require treatment outside pregnancy and are often misdiagnosed with type 1 or type 2 diabetes
Acute Hyperglycemic Crises
Hyperosmolar hyperglycemic state (HHS) represents severe persistent hyperglycemia characterized by 5:
- Marked elevation of blood glucose (often >600 mg/dL)
- Hyperosmolarity and profound dehydration
- Little or no ketosis (distinguishing it from DKA)
- More common in type 2 diabetes
Key Clinical Pitfalls
Don't miss the fasting component: Controlling hepatic glucose output through bedtime intermediate-acting (NPH) or long-acting basal insulin (glargine) is essential for managing persistent fasting hyperglycemia 2
Avoid sliding-scale-only regimens: This approach is inadequate and a major contributor to persistent hyperglycemia in hospitalized patients 4
Consider genetic causes in atypical presentations: Young patients with mild persistent hyperglycemia and strong family history may have GCK-MODY and should undergo genetic testing to avoid unnecessary lifelong treatment 6
Address the inflammatory component: Persistent hyperglycemia activates immune dysregulation with elevated proinflammatory cytokines, creating additional metabolic stress 7
Recognize that even modest persistent hyperglycemia causes lasting damage: Pathophysiologic changes persist and promote complications years later, even after glucose control is achieved 3. The duration of glycemic burden strongly predicts adverse outcomes 1.